Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30144% above fair value
$55.93+0.53 (+0.96%)
Close on Nov 13, 2026Market cap $3.34BP/E –Yield –
Axogen operating margin
Operating margin is operating income as a percentage of revenue.
Axogen's operating margin for the twelve months ending Sep 30, 2026 was -5.2%. For fiscal 2025 it was -3.5%, against -1.8% the year before. The highest annual figure on record is -1.8% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3.5% | −1.7 |
| FY2024 | Dec 31, 2024 | -1.8% | +11.7 |
| FY2023 | Dec 31, 2023 | -13.5% | +7.9 |
| FY2022 | Dec 31, 2022 | -21.4% | −1.5 |
| FY2021 | Dec 31, 2021 | -20.0% | +0.7 |
| FY2020 | Dec 31, 2020 | -20.6% | +8.8 |
| FY2019 | Dec 31, 2019 | -29.4% | −5.0 |
| FY2018 | Dec 31, 2018 | -24.4% | −11.3 |
| FY2017 | Dec 31, 2017 | -13.2% | +6.6 |
| FY2016 | Dec 31, 2016 | -19.8% | +14.1 |
| FY2015 | Dec 31, 2015 | -33.9% | +24.4 |
| FY2014 | Dec 31, 2014 | -58.3% | +29.3 |
| FY2013 | Dec 31, 2013 | -87.6% | +13.8 |
| FY2012 | Dec 31, 2012 | -101.4% | +42.3 |
| FY2011 | Dec 31, 2011 | -143.7% | +5.5 |
| FY2010 | Dec 31, 2010 | -149.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 1.3% | −1.9 |
| Q2 FY2026 | Jun 30, 2026 | -3.1% | −6.0 |
| Q1 FY2026 | Mar 31, 2026 | -4.6% | −1.2 |
| Q4 FY2025 | Dec 31, 2025 | -16.3% | −20.4 |
| Q3 FY2025 | Sep 30, 2025 | 3.2% | +3.8 |
| Q2 FY2025 | Jun 30, 2025 | 3.0% | +3.8 |
| Q1 FY2025 | Mar 31, 2025 | -3.4% | +7.6 |
| Q4 FY2024 | Dec 31, 2024 | 4.1% | +11.5 |
| Q3 FY2024 | Sep 30, 2024 | -0.6% | +9.1 |
| Q2 FY2024 | Jun 30, 2024 | -0.9% | +17.2 |
| Q1 FY2024 | Mar 31, 2024 | -11.0% | +9.0 |
| Q4 FY2023 | Dec 31, 2023 | -7.4% | +8.1 |
| Q3 FY2023 | Sep 30, 2023 | -9.8% | +3.4 |
| Q2 FY2023 | Jun 30, 2023 | -18.1% | +4.9 |
| Q1 FY2023 | Mar 31, 2023 | -20.0% | +16.5 |
| Q4 FY2022 | Dec 31, 2022 | -15.5% | +1.5 |
| Q3 FY2022 | Sep 30, 2022 | -13.1% | +8.3 |
| Q2 FY2022 | Jun 30, 2022 | -23.0% | −1.7 |
| Q1 FY2022 | Mar 31, 2022 | -36.5% | −16.5 |
| Q4 FY2021 | Dec 31, 2021 | -17.0% | −0.4 |
| Q3 FY2021 | Sep 30, 2021 | -21.4% | −18.3 |
| Q2 FY2021 | Jun 30, 2021 | -21.3% | +16.0 |
| Q1 FY2021 | Mar 31, 2021 | -20.0% | +15.0 |
| Q4 FY2020 | Dec 31, 2020 | -16.5% | +9.8 |
| Q3 FY2020 | Sep 30, 2020 | -3.1% | +18.3 |
| Q2 FY2020 | Jun 30, 2020 | -37.3% | −8.6 |
| Q1 FY2020 | Mar 31, 2020 | -35.1% | +8.7 |
| Q4 FY2019 | Dec 31, 2019 | -26.3% | −1.4 |
| Q3 FY2019 | Sep 30, 2019 | -21.4% | −0.1 |
| Q2 FY2019 | Jun 30, 2019 | -28.7% | −5.3 |
| Q1 FY2019 | Mar 31, 2019 | -43.8% | −14.9 |
| Q4 FY2018 | Dec 31, 2018 | -25.0% | −14.3 |
| Q3 FY2018 | Sep 30, 2018 | -21.3% | −12.0 |
| Q2 FY2018 | Jun 30, 2018 | -23.4% | −13.9 |
| Q1 FY2018 | Mar 31, 2018 | -28.9% | −2.8 |
| Q4 FY2017 | Dec 31, 2017 | -10.6% | +13.2 |
| Q3 FY2017 | Sep 30, 2017 | -9.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -9.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -26.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -23.8% | – |
See a number that looks wrong?